Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients

Lipids

Volumn 48, Issue 9, 2013, Pages 879-888

  Mocellin, Michel Carlos ^a   Pastore E Silva, Juliana De Aguiar ^b   Camargo, Carolina De Quadros ^a   Fabre, Maria Emília De Souza ^b   Gevaerd, Scheila ^b   Naliwaiko, Katya ^c   Moreno, Yara Maria Franco ^a   Nunes, Everson Araújo ^a   Trindade, Erasmo Benicio Santos De Moraes ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Ambulatory Care Clinic and Oncologic Research Center   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Chemotherapy; Colorectal cancer; Cytokines; Fatty acid profile; Fish oil; n 3 Polyunsaturated fatty acids

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY MASS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; LIFESTYLE; MALE; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; WEIGHT REDUCTION;

ADULT; AGED; ANIMALS; BODY MASS INDEX; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DRUG ADMINISTRATION SCHEDULE; EICOSAPENTAENOIC ACID; FATTY ACIDS; FEMALE; FISH OILS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROGNOSIS; PROSPECTIVE STUDIES; SERUM ALBUMIN; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883176879     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-013-3816-0     Document Type: Article

References (43)

1. Connolly JM, Coleman M, Rose DP (1997) Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer 29:114-119
2. Connolly JM, Gilhooly EM, Rose DP (1999) Effects of reduced dietary linoleic acid intake, alone or combined with an algae source of docosahexaenoic acid on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr Cancer 35:44-49
3. Calder PC, Davis J, Yaqoob P et al (1998) Dietary fish oil suppresses human colon tumor growth in athymic mice. Clin Sci 94:303-311
4. Chen ZY, Istfan NW (2000) Docohexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukot Essent Fatty Acids 63:301-308
5. Jordan A, Stein J (2003) Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2. Eur J Nutr 42:324-331
6. DeGraffenried LA, Friedrichs WE, Fulcher L et al (2003) Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Ann Oncol 14:969-970
7. Feng Z, Hu W, Marnett LJ et al (2006) Malondialdehyde, a major endogenous lipid peroxidation product, sensitizes human cells to UV- and BPDE-induced killing and mutagenesis through inhibition of nucleotide excision repair. Mutat Res 601:125-136
8. Moses AW, Slater C, Preston T et al (2004) Reduced total energy expenditure and physical activity in cachexia patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90:996-1002
9. Colomer R, Moreno-Nogueira JM, García-Luna PP et al (2007) n-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97:823-831
10. Bonatto SR, Oliveira HP, Nunes EA et al (2012) Fish oil supplementation improves neutrophil function during cancer chemotherapy. Lipids 47:383-389
11. Cury-Boaventura MF, Torrinhas RS, Godoy AB et al (2012) Human leukocyte death after a preoperative infusion of medium/long-chain triglyceride and fish oil parenteral emulsions: a randomized study in gastrointestinal cancer patients. JPEN J Parenter Enteral Nutr 36(6):677-684
12. Cockbain AJ, Toogood GJ, Hull MA (2012) Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 61:135-149
13. Janakiram NB, Mohammed A, Rao CV (2011) Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer Metastasis Rev 30:507-523
14. Hull MA (2011) Omega-3 polyunsaturated fatty acids. Best Pract Res Clin Gastroenterol 25:547-554
15. 3 from eicosapentaenoic acid in human lung cancer cells. J Lipid Res 45:1030-1039
16. Chapkin RS, Kim W, Lupton JR et al (2009) Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 81:187-191
17. Szkaradkiewicz A, Marciniak R, Chudzicka-Strugała I et al (2009) Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients. Arch Immunol Ther Exp 57:291-294
18. Chung YC, Chang YF (2003) Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur J Gastroenterol Hepatol 15:369-373
19. Rickham PP (1964) Human experimentation. Code of ethics of the World Medical Association. Declaration of Helsinki. Br Med J 2:0-177
20. Peltola H, Valmari P (1985) Serum C-reactive protein as detector of pretreated childhood bacterial meningitis. Neurology 35:251-253
21. Doumas BT, Watson WA, Biggs HG (1971) Albumin standards and the measurement of serum albumin with bromocresol green. Clin Chim Acta 31:87-96
22. Corrêa CR, Angelili AO, Camargo NR et al (2002) Comparação entre a relação PCR/albumina e o índice prognóstico inflamatório nutricional (IPIN). Jornal Brasileiro de Patologia e Medicina Laboratorial 38:183-190
23. Lohman TG, Roche AF, Martorell R (1988) Anthropometric standardization reference manual. Human Kinetics, Champaign
24. World Health Organization (1998) Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO, Geneva
25. Detsky AS, McLaughlin JR, Baker JP et al (1987) What is subjective global assessment of nutritional status? J Parenter Enter Nutr 11:8-13
26. Durnin JV, Womersley J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97
27. Braga M, Gianotti L, Vignali A et al (2002) Preoperative oral arginine and fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 132:805-814
28. Matsuda A, Furukawa K, Takasaki H et al (2006) Preoperative oral immune-enhancing nutritional supplementation corrects Th1/Th2 imbalance in patients undergoing elective surgery for colorectal cancer. Dis Colon Rectum 49:507-516
29. Read JA, Beale PJ, Volker DH et al (2007) Nutrition intervention using an eicosapenatenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer 15:301-307
30. Liang B, Wang S, Ye YJ et al (2008) Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J Gastroenterol 21:2434-2439
31. Silva JA, Trindade EB, Fabre ME et al (2012) Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr Cancer 64:267-273
32. Zhu MW, Tang DN, Hou J et al (2012) Impact of fish oil enriched total parenteral nutrition on elderly patients after colorectal cancer surgery. Chin Med J 125:178-181
33. Purasiri P, Murray A, Richardson S et al (1994) Modulation of cytokine in vivo by dietary essential fatty acids in patients with colorectal cancer. Clin Sci 87:711-717
34. Erlinger TP, Platz EA, Rifai N et al (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585-590
35. Gunter MJ, Stolzenberg-Solomon R, Cross AJ et al (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66:2483-2487
36. Il'yasova D, Colbert LH, Harris TB et al (2005) Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14:2413-2418
37. Shiu YC, Lin JK, Huang CJ et al (2008) Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum 51:443-449
38. Ingembleek Y, Carpentier Y (1984) A prognostic inflammatory and nutritional index scoring critically ill patients. Internat J Vit Nutr Res 55:91-101
39. Wu S, Rhee KJ, Albesiano E et al (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15:1016-1022
40. Chae WJ, Gibson TF, Zelterman D et al (2010) Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. PNAS 107:5540-5544
41. Chae WJ, Bothwell AL (2011) IL-17 and intestinal tumorigenesis. Drugs Discov Today: Dis Mech 8:e79-e83
42. Sánchez LK, Ugalde ME, Motola KD et al (2012) Gastrointestinal symptoms and weight loss in cancer patients receiving chemotherapy. Br J Nutr 12:1-4
43. Furukawa T, Tashiro H, Yamamori K et al (1999) Effects of soybean oil emulsion and eicosapentaenoic acid on stress response and immune function after a severely stressful operation. Ann Surg 229:255-261